SCHEMBL5246201

SCHEMBL5246201

C=CCc1[c]nccc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067166 0.77 IMPDH2 (0.36)
SCHEMBL2067217 0.77 XDH (0.37)
SCHEMBL3516652 0.72
SCHEMBL8076152 0.69 BCL2 (0.33)
SCHEMBL7190874 0.67 ALDH1A1 (0.31)
SCHEMBL2067168 0.65 IMPDH2 (0.33)
SCHEMBL2067220 0.65 GABRA1 (0.40)
SCHEMBL299910 0.64
SCHEMBL2067857 0.62 KDM4E (0.33)
SCHEMBL3649976 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1832586-A1 Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas Oridis Biomed Forschungs- und Entwicklungs GmbH (AT) 2007-09-12 EP claimed
EP-1832586-A1 Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas Oridis Biomed Forschungs- und Entwicklungs GmbH (AT) 2007-09-12 EP disclosed